Nissreen Elfadawy, MD
-
Specialty: Nephrology
View Expertise -
Primary Location: 13221 Ravenna Rd (21 mi.)
Other Locations - Languages Spoken: English, Arabic
Office Locations
UH Geauga Health Center One (21 mi.)
13221 Ravenna Rd
Ste 12
Chardon, OH 44024
440-285-3055
Biography: Nissreen Elfadawy, MD
Expertise
Titles
- Vice Chair, Department of Medicine, UH Regional Hospitals Geauga Campus
- Clinical Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Nephrology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Nephrology
Nephrology - UH Cleveland Medical Center (2017 - 2019)
Residency | Internal Medicine
Internal Medicine - UH Cleveland Medical Center (2015 - 2017)
Fellowship | Transplant Nephrology
Transplant Nephrology - Cleveland Clinic (2013 - 2014)
Research Fellowship | Urology
Urology - Cleveland Clinic (2011 - 2015)
Medical Education
Alexandria University (2002)
About
Nissreen Elfadawy, MD, MS, FASN, FAST, is a staff nephrologist at University Hospitals Geauga Medical Center in Chardon. She is an Assistant Professor of Medicine at Case Western Reserve University School of Medicine and is board-certified in medicine. Her special interests include chronic kidney disease, hypertension, acute kidney injury, glomerulonephritis, electrolyte disorders, diabetic nephropathy, onco-nephrology and kidney transplantation.
Dr. Elfadawy earned her medical degree from Alexandria University in Egypt, where she also completed an internship and a residency in Internal Medicine. She obtained her Master’s degrees in Internal Medicine from Alexandria University before joining the Cleveland Clinic. She completed a research fellowship and a clinical kidney transplant fellowship at Cleveland Clinic. She also finished an internal medicine residency and a general nephrology fellowship at University Hospitals.
Dr. Elfadawy received many awards during her training from University Hospitals, American Society of Nephrology and American Society of Transplantation (AST). She also served as a Chair of the Trainee and Young Faculty community of practice at the AST.
Dr. Elfadawy has written several peer-reviewed articles, abstracts and book chapters focusing on kidney disease and complications after kidney transplant. Dr. Elfadawy has also served as a reviewer for many prominent medical journals focusing on general nephrology and transplant nephrology. She is an active fellow of the American Society of Nephrology and the American Society of Transplantation.
Patient Experience Reviews
Very good experience first visit will see her in three months
She was professional and business-like as well as warm and friendly.
Very good care from this doctor.
Good experience
This doctor and the receptionist made for a very comfortable appointment. I thought the doctor was the nicest and the best. The receptionist was great!
The office visit was excellent. ***
Dr. Elfadawy is a great doctor. She is very nice and knowledgeable about kidney disease, as she is a nephrologist.
Very good experience
Dr was very good and attentive to my condition
Happy with the kidney Doctor
Doctor Elfedaway is the nicest caring Doctor I have ever had, very thoughtful and helpful.
Very friendly and kind
She was very good
She was very clear w her explanation and interested in my feelings and answers. I liked instantly and feel I'm getting excellent advice and care.
Loved the Doctor and the staff!!!!
She explained everything extremely well that I can understand. She had answers for any question that I had.
Wonderful Doctorone of the best I have ever seem
The Dr, and her staff is awesome,makes you feel like a person and not just another number
For meeting the Doctor for the first time wefelt very comfortable
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Nissreen Elfadawy did not disclose any Outside Relationships with Industry.